Suppr超能文献

详细分析人小肠中的益生元果寡糖和半乳糖寡糖。

Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine.

机构信息

Division of Human Nutrition and Health, Wageningen University, Wageningen 6708 WE, The Netherlands.

Laboratory of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University of Groningen, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands.

出版信息

J Agric Food Chem. 2024 Sep 25;72(38):21152-21165. doi: 10.1021/acs.jafc.4c03881. Epub 2024 Sep 16.

Abstract

Galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are food ingredients that improve human health, but their degradation throughout the human small intestine is not well understood. We studied the breakdown kinetics of FOS and GOS in the intestines of seven healthy Dutch adults. Subjects were equipped with a catheter in the distal ileum or proximal colon and consumed 5 g of chicory-derived FOS (degree of polymerization (DP) DP2-10), and 5 g of GOS (DP2-6). Postprandially, intestinal content was frequently collected until 350 min and analyzed for mono-, di-, and oligosaccharides. FOS and GOS had recoveries of 96 ± 25% and 76 ± 28%, respectively. FOS DP ≥ 2 and GOS DP ≥ 3 abundances in the distal small intestine or proximal colon matched the consumed doses, while GOS dimers (DP2) had lower recoveries, namely 22.8 ± 11.1% for β-D-gal-(1↔1)-α-D-glc+β-D-gal-(1↔1)-β-D-glc, 19.3 ± 19.1% for β-D-gal-(1 → 2)-D-glc+β-D-gal-(1 → 3)-D-glc, 43.7 ± 24.6% for β-D-gal-(1 → 6)-D-gal, and 68.0 ± 38.5% for β-D-gal-(1 → 4)-D-gal. Lactose was still present in the distal small intestine of all of the participants. To conclude, FOS DP ≥ 2 and GOS DP ≥ 3 were not degraded in the small intestine of healthy adults, while most prebiotic GOS DP2 was hydrolyzed in a structure-dependent manner. We provide evidence on the resistances of GOS with specific β-linkages in the human intestine, supporting the development of GOS prebiotics that resist small intestine digestion.

摘要

半乳糖寡糖(GOS)和低聚果糖(FOS)是改善人类健康的食品成分,但它们在人类小肠内的降解过程尚不清楚。我们研究了 7 名健康荷兰成年人小肠内 FOS 和 GOS 的分解动力学。受试者在回肠末端或近端结肠内置入导管,并摄入 5g 菊苣衍生的 FOS(聚合度(DP)DP2-10)和 5g GOS(DP2-6)。餐后,频繁采集肠道内容物,直至 350 分钟,并分析单糖、二糖和低聚糖。FOS 和 GOS 的回收率分别为 96±25%和 76±28%。FOS DP ≥ 2 和 GOS DP ≥ 3 在回肠末端或近端结肠的丰度与摄入剂量相匹配,而 GOS 二聚体(DP2)的回收率较低,即β-D-半乳糖(1↔1)-α-D-葡萄糖+β-D-半乳糖(1↔1)-β-D-葡萄糖为 22.8±11.1%,β-D-半乳糖(1 → 2)-D-葡萄糖+β-D-半乳糖(1 → 3)-D-葡萄糖为 19.3±19.1%,β-D-半乳糖(1 → 6)-D-半乳糖为 43.7±24.6%,β-D-半乳糖(1 → 4)-D-半乳糖为 68.0±38.5%。所有参与者的回肠末端仍存在乳糖。总之,健康成年人的小肠内未降解 FOS DP ≥ 2 和 GOS DP ≥ 3,而大多数结构依赖的益生元 GOS DP2 被水解。我们提供了人类肠道中特定β键 GOS 具有抗性的证据,支持开发可抵抗小肠消化的 GOS 益生元。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/11440495/367bd98cb2b3/jf4c03881_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验